ACTRN12611000266965终止未知
Apoptosis detection using Technetium 99m labelled Annexin V SPECT/CT imaging to determine chemotherapy response in patients with Malignant Pleural Mesothelioma following initiation of chemotherapy treatment.
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Histologically confirmed malignant Mesothelioma
- •ECOG performance status 0-2
- •> 18 years of age
- •Able to undertake SPECT/CT and PET/CT imaging
- •Written informed consent
排除标准
- •Age < 18 years
- •Medical contraindication to SPECT/CT or PET/CT imaging.
- •Cognitive impairment considered to impair the ability to give written informed consent in the opinion of the treating clinician.
研究者
相似试验
进行中（未招募）
1 期
Scintigraphic detection of tumor necrosis factor with radioactive labeled TNFa-blocker in patients with active rheumatoid arthritis and active axial and peripheric spondyloarthropathy.EUCTR2009-017998-37-BEGhent University Hospital36
已完成
不适用
Technetium-99m HMPAO granulocyte scintigraphy as a tool to measure inflammatory load in Ulcerative Colitis: a cross-sectional studyInflammatory Bowel Diseasehttps://toetsingonline.ccmo.nl/ccmomon.nsf/0/A1A4F7B322EF7BF6C12579EC003742B8?EditDocument10017969Ulcerative ColitisNL-OMON37564Academisch Medisch Centrum30
终止
1 期
Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate CancerProstate CancerNCT00989105Cancer Research UK8
Unknown
不适用
The Role of the Novel 99mTc-NC100692 Tracer in Patients at High Risk or Known Breast CancerTumor AngiogenesisBreast CancerNCT01503697Tel-Aviv Sourasky Medical Center75
招募中
不适用
Development of cancer immune evaluation toolNeoplasmsKCT0002469Seoul Songdo Hospital500